These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 34419948)

  • 1. Epigenetic Modification Drives Acute Kidney Injury-to-Chronic Kidney Disease Progression.
    Li Z; Li N
    Nephron; 2021; 145(6):737-747. PubMed ID: 34419948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic Changes in the Acute Kidney Injury-to-Chronic Kidney Disease Transition.
    Nangaku M; Hirakawa Y; Mimura I; Inagi R; Tanaka T
    Nephron; 2017; 137(4):256-259. PubMed ID: 28595179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia as a key player in the AKI-to-CKD transition.
    Tanaka S; Tanaka T; Nangaku M
    Am J Physiol Renal Physiol; 2014 Dec; 307(11):F1187-95. PubMed ID: 25350978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting the transition of acute kidney injury to chronic kidney disease: Potential mechanisms and future perspectives.
    Ogbadu J; Singh G; Aggarwal D
    Eur J Pharmacol; 2019 Dec; 865():172711. PubMed ID: 31589870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-coding RNAs in kidney injury and repair.
    Liu Z; Wang Y; Shu S; Cai J; Tang C; Dong Z
    Am J Physiol Cell Physiol; 2019 Aug; 317(2):C177-C188. PubMed ID: 30969781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential targeted therapy and diagnosis based on novel insight into growth factors, receptors, and downstream effectors in acute kidney injury and acute kidney injury-chronic kidney disease progression.
    Gao L; Zhong X; Jin J; Li J; Meng XM
    Signal Transduct Target Ther; 2020 Feb; 5(1):9. PubMed ID: 32296020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular communication network factor 2 (CCN2) promotes the progression of acute kidney injury to chronic kidney disease.
    Inoue T; Kusano T; Amano H; Nakamoto H; Okada H
    Biochem Biophys Res Commun; 2019 Sep; 517(1):96-102. PubMed ID: 31320136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct patterns of transcriptional and epigenetic alterations characterize acute and chronic kidney injury.
    Sharifian R; Okamura DM; Denisenko O; Zager RA; Johnson A; Gharib SA; Bomsztyk K
    Sci Rep; 2018 Dec; 8(1):17870. PubMed ID: 30552397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Kidney Injury to Chronic Kidney Disease Transition.
    Fiorentino M; Grandaliano G; Gesualdo L; Castellano G
    Contrib Nephrol; 2018; 193():45-54. PubMed ID: 29393158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of LncRNAs in AKI-to-CKD transition: A therapeutic and diagnostic viewpoint.
    Puri B; Majumder S; Gaikwad AB
    Life Sci; 2024 Apr; 342():122509. PubMed ID: 38387702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic regulation in AKI and kidney repair: mechanisms and therapeutic implications.
    Guo C; Dong G; Liang X; Dong Z
    Nat Rev Nephrol; 2019 Apr; 15(4):220-239. PubMed ID: 30651611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial dysfunction and the AKI-to-CKD transition.
    Jiang M; Bai M; Lei J; Xie Y; Xu S; Jia Z; Zhang A
    Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1105-F1116. PubMed ID: 33073587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic reprogramming driving successful and failed repair in acute kidney injury.
    Muto Y; Dixon EE; Yoshimura Y; Ledru N; Kirita Y; Wu H; Humphreys BD
    Sci Adv; 2024 Aug; 10(32):eado2849. PubMed ID: 39110788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapies Targeting Epigenetic Alterations in Acute Kidney Injury-to-Chronic Kidney Disease Transition.
    Tanemoto F; Mimura I
    Pharmaceuticals (Basel); 2022 Jan; 15(2):. PubMed ID: 35215236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose hydralazine prevents fibrosis in a murine model of acute kidney injury-to-chronic kidney disease progression.
    Tampe B; Steinle U; Tampe D; Carstens JL; Korsten P; Zeisberg EM; Müller GA; Kalluri R; Zeisberg M
    Kidney Int; 2017 Jan; 91(1):157-176. PubMed ID: 27692563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms.
    He L; Wei Q; Liu J; Yi M; Liu Y; Liu H; Sun L; Peng Y; Liu F; Venkatachalam MA; Dong Z
    Kidney Int; 2017 Nov; 92(5):1071-1083. PubMed ID: 28890325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the Mechanisms of the Acute Kidney Injury-to-Chronic Kidney Disease Continuum.
    Takaori K; Yanagita M
    Nephron; 2016; 134(3):172-176. PubMed ID: 27398799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FoxO3 activation in hypoxic tubules prevents chronic kidney disease.
    Li L; Kang H; Zhang Q; D'Agati VD; Al-Awqati Q; Lin F
    J Clin Invest; 2019 Mar; 129(6):2374-2389. PubMed ID: 30912765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of endoplasmic reticulum stress and autophagy in the transition from acute kidney injury to chronic kidney disease.
    Habshi T; Shelke V; Kale A; Anders HJ; Gaikwad AB
    J Cell Physiol; 2023 Jan; 238(1):82-93. PubMed ID: 36409755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vegfa promoter gene hypermethylation at HIF1α binding site is an early contributor to CKD progression after renal ischemia.
    Sánchez-Navarro A; Pérez-Villalva R; Murillo-de-Ozores AR; Martínez-Rojas MÁ; Rodríguez-Aguilera JR; González N; Castañeda-Bueno M; Gamba G; Recillas-Targa F; Bobadilla NA
    Sci Rep; 2021 Apr; 11(1):8769. PubMed ID: 33888767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.